Bratha

Part 1.2 - How to Actually Track and Decide

16 min read

This is Part 2 of 3 in the Hair Series. The full path:

Table of Contents

Bridge from Part 1.1

Part 1.1 established the what — that follicles are finite, that the slide from healthy terminal to fibrosis is what we’re racing against, and that three KPIs (T:V ratio, density, average shaft diameter) measure where any given zone actually sits on that slide.

This article is the how: given your starting point, how do you anchor a baseline that’s actually trustworthy, how do you re-measure honestly at 6 and 12 months, how do you read the results, and how do you decide what to change in the protocol when things aren’t moving the way they should?

Why 6 months, not 3

Hair cycles are slow. Anagen lasts 2–7 years. Telogen lasts ~3 months. The time from “DHT signal removed” to “follicle re-enters productive anagen with a measurably thicker shaft” is months, not weeks.

Re-measuring at 3 months gives you noise. Re-measuring at 6 months gives you signal. The industry standard for trichology re-evaluation is 6 months for exactly this reason — anything faster will either show a meaningless delta or, worse, will catch you mid-shed and produce a false “the stack isn’t working” panic.

The cadence Day 1 → Month 6 → Month 12, then re-anchor every 12 months thereafter. Daily/weekly at-home shed-pattern observation is fine for vibes — but the data that drives protocol decisions only comes from the 6-month and 12-month clinic scans.

The baseline lock-in

The Day-1 baseline is the single most important data point in the entire protocol, because every future change is measured against it. If the baseline is sloppy, every subsequent comparison is meaningless.

The lock-in protocol is short:

  1. Book a clinic scan as close to “Day 1 of the protocol” as possible. Tier 2 (commercial scalp center like Hair Doc, Yun Nam, Feathair — RM50–RM119 range) is the affordable baseline. Tier 3 (board-certified dermatologist or hair transplant surgeon with digital trichoscopy, RM300–RM800) is the gold standard. Most people will use Tier 2 for the baseline and consider Tier 3 for the 12-month peak evaluation.
  2. Let the clinic identify the target zones. This is what they do well. They’ll examine the scalp under magnification and tell you which zones show active miniaturization (state 2), which are healthy (state 1), and which are slick/fibrosed (state 3). Trust their zone selection — they have better lighting, better magnification, and a calibrated eye for this than any at-home setup.
  3. Demand a copy of the trichoscopy images and density readings before leaving. Not “we’ll email it later”, not “it’s in the file” — a physical or digital copy of the actual numbers and microscopy images in your hand. Without this, you have nothing to compare against in 6 months.
  4. Record the three KPIs explicitly for each target zone the clinic flags: T:V ratio, density (hairs/cm²), average shaft diameter (μm). These are the comparison anchors.
  5. (Optional) Capture a smartphone shed-baseline photo set. Front, top-down, sides, back, under harsh overhead light, hair clean and dry. Useful for visible self-reference between clinic scans. The clinic photos remain the canonical record.

On photo protocol The clinic has their own standardized photo apparatus (fixed distance, controlled lighting, often a polarized lens). Their photos are the trustworthy comparison. Your smartphone photos are for noticing obvious changes between visits, not for measurement.

The clinic strategy: Tier 2 vs. Tier 3

The same Tier framing introduced in Part 1.1 determines how to use these two channels.

Use Tier 2 for routine 6-month data

Commercial scalp centers (Hair Doc, Yun Nam, Feathair, and equivalents) are the affordable, repeatable diagnostic channel. The scan portion of their service is genuinely useful — digital trichoscopy produces real density readings and microscopic images.

Use them strictly for data collection, not for their treatment packages. Two reasons:

  • The packages (RM4,000–RM16,000+) are sold on the back of the scan, often by pivoting from “here’s your scalp damage” to “here’s our 6-month treatment plan that will fix it.” The pressure is real and standardized.
  • The serums and infusions in the packages (apple stem cells, Capixyl, generic peptide blends) are cosmetically weak compared to the pharmacology that the rest of this series covers. Paying RM10,000+ for weak topicals while running RU58841 and minoxidil at home is paying twice for less.

The script Walk in, pay the promo rate for the scan-only or minimum-package option, get the scan, demand a copy of the trichoscopy images and density numbers before leaving the chair, decline every package upsell politely and leave. The data is what you came for. Everything else is overhead.

Use Tier 3 for the baseline and the 12-month peak

A board-certified dermatologist specializing in hair loss (trichologist) or a reputable hair transplant surgeon, using clinical-grade digital trichoscopy or a phototrichogram, produces the most precise zone-mapped longitudinal data. Cost is higher and the appointments are less frequent, but the data is more trustworthy.

The split that works:

  • Tier 3 at Day 1 — anchor the baseline with the most precise data possible.
  • Tier 2 every 6 months — track movement at affordable cost.
  • Tier 3 at Month 12 — peak evaluation, definitive comparison against the baseline.

Heads-up if you're running a heavy stack Conventional dermatology clinics will strongly advise FDA-approved treatments only (finasteride, minoxidil) and warn against research compounds (RU58841, alpha-estradiol, peptides). Go in with the goal of diagnostic mapping of follicle viability, not protocol validation. Knowing precisely where you have salvageable follicles vs. fibrosed zones is the point. The stack rationale comes from your own reading, not the consult.

What the trichoscopy actually shows

The clinic isn’t just looking to confirm hair is present. A digital trichoscope is evaluating three specific things1:

  • Miniaturization percentage — the exact ratio of full-thickness terminal hairs to shrunken vellus hairs in a fixed square centimeter. A zone with >20% miniaturized hairs indicates active balding — and crucially, it proves the follicles are still alive and salvageable. The miniaturization percentage is essentially the inverse of the T:V ratio expressed as a percentage of vellus hairs.
  • Follicular unit density and grouping — healthy scalps produce groupings of 2, 3, or 4 hairs per follicular unit (one pore). When pores produce only single, lonely hairs, that’s early-stage thinning — the follicular unit is losing its companion hairs one by one.
  • Empty ostia (yellow dots / sealed pores) — pores that are still visible as openings but produce no hair, or pores that have completely sealed over with smooth skin. Empty ostia that still have visible structure are recoverable (a dormant follicle that minoxidil can wake up). Completely sealed-over pores are fibrosis — the diagnosis that confirms a chemical stack cannot help that specific zone.

The diagnostic translation When the clinic report says "X% miniaturization, Y hairs/cm² density, Z μm average shaft, N% empty ostia in target zone Q," it's saying: "Zone Q has N% of its original pore count permanently dead, the remaining living follicles are X% miniaturized, currently producing Y hairs per square centimeter at an average thickness of Z μm." That's the picture the stack is being asked to improve.

The attribution map: which compound drives which KPI

This is the load-bearing concept of Part 1.2. When the three KPIs move (or don’t) at the 6-month re-scan, you need to know which compound in the stack was responsible for which movement. Without this, every protocol adjustment is a guess.

[Follicle State] ──► [1. Terminal-to-Vellus Ratio] ──► Driven by: Androgen receptor antagonists (RU58841) + Alpha-Estradiol
                 ──► [2. Follicular Unit Density]  ──► Driven by: Oral/Topical Minoxidil + Tretinoin
                 ──► [3. Average Shaft Diameter]   ──► Driven by: RU58841 (follicle expansion) + MK-677 + GHK-Cu (shaft thickening)

In table form:

KPIPrimary driver(s)Mechanism
Terminal-to-Vellus RatioRU58841, alpha-estradiol (and finasteride/dutasteride if used)Androgen blockade removes the miniaturization signal; vellus hairs convert back to terminal over successive growth cycles.
Follicular Unit DensityOral minoxidil, topical minoxidil + tretinoinMinoxidil forces dormant follicles back into anagen by opening potassium channels and flooding the follicle with blood and nutrients. Tretinoin upregulates the scalp sulfotransferase that converts minoxidil into its active metabolite.
Average Shaft DiameterRU58841 (allows follicle to expand to natural size), MK-677 (elevates IGF-1, thickens structural keratin), GHK-Cu (remodels micro-fibrosis around the bulb, enlarges the follicle)Combination of follicle health (not being choked by androgens) and systemic + localized growth signaling.

Read movement in the KPIs as a diagnostic readout of which mechanism is firing and which isn't. Density jumped but shaft diameter is flat? Minoxidil is working but the follicles aren’t expanding — that’s a shaft-thickening (GHK-Cu / MK-677) gap. T:V ratio is moving but density is flat? Androgens are being controlled but minoxidil isn’t recruiting dormant follicles — that’s a vasodilator gap.

The 12-month timeline

Because hair cycles move on a months-to-quarters timescale, the wrong check at the wrong interval leads to wrong conclusions. The timeline:

[Day 1: Baseline] ──► [Month 3: The Dread Shed] ──► [Month 6: First True Audit] ──► [Month 12: Peak Evaluation]

Day 1 — Baseline. Clinic scan, three KPIs recorded per target zone, protocol initiated.

Month 3 — Expect a shed. The combination of oral minoxidil + topical minoxidil + tretinoin will rapidly kick resting (telogen) follicles out of their cycle, producing what the community calls the “dread shed”. This is a positive sign, not a failure — old weak hairs are being pushed out to make way for thicker terminal shafts in the next cycle. Do not panic. Do not alter the protocol. If panic-quitting happens here, the next 9 months of recovery are forfeited.

Month 6 — First true audit. Book the second clinic scan. Compare against the Day-1 baseline using the same three KPIs in the same zones. This is the first honest data point on whether the protocol is working. Use the decision tree below to interpret what you find and decide what (if anything) to change.

Month 12 — Peak evaluation. The new baseline locks in. Re-scan, ideally at Tier 3 (board-certified dermatologist). This is where the definitive maximum capability of the chemical stack on your specific scalp becomes visible. If a zone is still completely smooth and bare at 12 months despite the full stack, it is fibrosed and only surgery (hair transplantation) will fill it.

TimingWhat to doWhat to look for
Day 1Tier 3 baseline scan (or Tier 2 if budget-constrained)Three KPIs per target zone, copy of images, written report
WeeklyOptional smartphone photos under identical lightStabilization of obvious shedding, not regrowth
Month 3Hold the protocolDread shed — expected and positive
Month 6Tier 2 re-scanMovement in the three KPIs, run the decision tree
Month 12Tier 3 re-scanPeak protocol output, decision on whether transplant is needed for any fibrosed zones

The 6-month re-scan: diagnostic decision tree

The Month-6 audit produces one of four scenarios. Each has a specific diagnosis and a specific action — the same Symptom → Diagnosis → Action structure used in the Fit Series decision branches.

Branch 1: Partial response (T:V improving, density flat)

All three KPIs moving in the right direction by Month 6, with density gains visible at Month 12.

  • Symptom: Terminal-to-vellus ratio is improving (existing wispy hairs are thickening back toward terminal), but follicular density isn’t moving — empty ostia haven’t been re-recruited.
    • Diagnosis: Androgen control is working. RU58841 and alpha-estradiol are doing their job. But the vasodilator side of the stack isn’t recruiting dormant follicles back into anagen.
    • Action: Audit minoxidil concentration and adherence — is the topical actually being applied to the full target zone, not just the most obvious patches? Is the oral dose at the lower end of its range when it could be at the higher end? Confirm tretinoin is still being layered on the minoxidil application nights (the sulfotransferase upregulation is what makes the minoxidil bioavailable). Re-evaluate at the 12-month scan.

Branch 2: Wake without thickening (density up, shaft flat)

Density gains paired with shaft diameter increases, producing a visibly thicker overall look.

  • Symptom: Follicular density is rising (empty ostia are sprouting again, single-hair groupings are becoming double-hair groupings), but average shaft diameter isn’t moving — the new hairs are coming in thin.
    • Diagnosis: Minoxidil is doing its job (waking dormant follicles), but the shaft-thickening signaling isn’t firing strongly enough. Either RU58841 isn’t fully suppressing local androgen binding in the target zone, or the systemic growth signal (IGF-1) is insufficient, or peptide support (GHK-Cu) isn’t reaching the follicle.
    • Action: If GHK-Cu isn’t already in the stack, add it. If MK-677 isn’t being cycled, consider an 8-week cycle to elevate IGF-1 and structurally thicken the new shafts. Confirm RU58841 vehicle (the carrier) is absorbing properly — PG/ethanol concentration matters for delivery.

Branch 3: No response (all three flat)

Any honest movement on any of the three KPIs at Month 6.

  • Symptom: Zero meaningful movement on any of the three KPIs after six months of consistent stack application.
    • Diagnosis: One of three things is true. Either (a) the stack isn’t actually being applied as consistently as believed (adherence failure), (b) the vehicle isn’t delivering the active compound through the scalp (absorption failure), or (c) the target zone has more fibrosis than the at-home macro check revealed and the living follicle count is below the threshold needed for visible response.
    • Action: First, audit application — track every dose for 4 weeks and confirm the schedule from Part 2.0 is being followed exactly. Second, switch vehicle if RU58841 absorption is suspect (different PG/ethanol ratios produce different penetration). Third, book a Tier 3 clinical trichoscopy specifically to quantify empty-ostia percentage in the target zone — if fibrosis is >50% of the zone, the chemical stack will not produce a visible response and hair transplantation becomes the realistic next step.

Branch 4: Mass shed (sudden meaningful shedding)

Stable shed counts in the normal 50–150 hairs/day range, no acute spike.

  • Symptom: A sudden, sustained jump in shed count well above baseline at any point during the 12 months — most commonly noticed in the shower or on the pillow rather than during a scan.
    • Diagnosis: Almost always telogen effluvium (TE) — a temporary shock-shed where a large fraction of follicles synchronously enter telogen and shed 3 months later. The two most common triggers in this stack: rapid weight loss from retatrutide (metabolic shock), or the initial minoxidil/tretinoin shed pushing weak hairs out (which is the good version of this — it’s the dread shed at Month 3, not a stack failure).
    • Action: If the shed is at Month 3, do nothing — maintain the stack, this is expected. If the shed is at any other time and correlates with aggressive caloric deficit or rapid weight loss, slow the retatrutide-driven rate of fat loss to <1% of bodyweight per week. TE is reversible — the follicles re-enter anagen 3–6 months after the trigger resolves.

Part 1.2 Takeaways

Key concepts to internalize

  • Re-measure at 6 months, not 3. Hair cycles too slowly for 3-month deltas to be signal. Month 6 is the first honest audit.
  • Lock the baseline at a clinic. Their photos, their numbers, their zone selection. Demand a copy of the trichoscopy images and density readings before leaving.
  • Use commercial scalp centers (Tier 2) for the scan only. Decline every package upsell. The data is the product; the serums are not.
  • Reserve Tier 3 (board-certified dermatologist) for the Day-1 baseline and the Month-12 peak evaluation. Tier 2 in between is enough.
  • The trichoscopy shows three things: miniaturization percentage, follicular unit density and grouping, and empty ostia (yellow dots vs. fully sealed pores).
  • Empty ostia that still show structure are recoverable; sealed-over pores are fibrosed. The fibrosis percentage in a zone determines whether the stack can help it.
  • The attribution map matters: RU58841 + alpha-E2 drive T:V ratio, minoxidil + tretinoin drive density, RU58841 + MK-677 + GHK-Cu drive shaft diameter. Read KPI movement as a diagnostic readout of which mechanism is firing.
  • The 12-month arc is Day 1 → Month 3 dread shed → Month 6 first true audit → Month 12 peak evaluation. Don’t panic at the Month 3 shed.
  • Four scenarios at the Month-6 audit: partial response, wake without thickening, no response, or mass shed. Each has a specific diagnosis and action.

Your Baseline-to-12-Month Task List

Before Part 2.0 (where the actual stack lives), set up the diagnostic loop that lets you evaluate it.

  1. Book the Day-1 baseline scan. Tier 3 if budget allows; Tier 2 (Hair Doc, Yun Nam, Feathair — RM50–RM119 range) otherwise. Schedule it within the same week the stack starts.
  2. Demand the data. Before leaving the chair: copy of trichoscopy images, density readings, T:V ratio, average shaft diameter, empty-ostia percentage per target zone. Refuse to leave without it.
  3. Decline every package. The clinic’s serums and infusions are not the protocol. The scan is the only thing being purchased.
  4. Lock the calendar. Add Month-6 and Month-12 re-scans to the calendar today. Same clinic for Month 6 (consistency over precision). Tier 3 for Month 12.
  5. Hold through the Month-3 shed. Expect it, document the shedding rate weekly, do not alter the stack.
  6. Run the Month-6 audit through the decision tree. Match the KPI movement to one of the four branches, apply the action.
  7. Re-anchor at Month 12. Tier 3 scan. Compare against Day 1, not Month 6 — the 12-month delta is the real measure of what the stack produced. If any zone is still slick and bare, it’s fibrosed, and the conversation shifts to hair transplantation.

Up next Part 2.0 — The Stack and the Routine covers the actual pharmacology: RU58841, alpha-estradiol, oral and topical minoxidil, tretinoin, ketoconazole, MK-677 on 8-week cycles, GHK-Cu and KPV peptide injections, and the explicit reasoning for deliberately not running finasteride or dutasteride. Plus the daily and weekly schedule that layers all of them without vehicle conflict.

Disclaimer Not medical advice. Everything here reflects personal experience and reading of the research. Several compounds discussed across this series — RU58841, alpha-estradiol, MK-677, retatrutide, GHK-Cu, KPV, and oral minoxidil at off-label doses — are not approved as treatments for hair loss in most jurisdictions and carry varying risk profiles. Consult a qualified physician and pull comprehensive bloodwork before running any of this.

Sources & references

Footnotes

  1. Trichoscopy diagnostic parameters (miniaturization percentage, follicular unit grouping, empty ostia / yellow dots): Rudnicka et al. (2008), “Trichoscopy: a new method for diagnosing hair loss,” J Drugs Dermatol; comprehensive review at PubMed — trichoscopy AGA. ↩

Graph View

Backlinks